MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells

Published:2023-03 Issue: Volume:31 Page:309-323
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Li Yan,Lian Di,Wang Jiahao,Zhao Yue,Li Yao,Liu Guoshi,Wu Sen,Deng Shoulong,Du Xuguang,Lian Zhengxing^ORCID

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

National Major Science and Technology Projects of China

National Science and Technology Planning Project

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference75 articles.

1. Development and applications of CRISPR-Cas9 for genome engineering;Hsu;Cell,2014

2. RNA-guided human genome engineering via Cas9;Mali;Science,2013

3. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013

4. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

5. CRISPR-Cas systems for editing, regulating and targeting genomes;Sander;Nat. Biotechnol.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell cycle arrest combined with CDK1 inhibition suppresses genome-wide mutations by activating alternative DNA repair genes during genome editing;Journal of Biological Chemistry;2024-09

2. Construction of a food-grade gene editing system based on CRISPR-Cas9 and its application in Lactococcus lactis NZ9000;Biotechnology Letters;2023-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP